THU-261 Monotherapy with the novel capsid assembly modulator ALG- 000184 for up to 96 weeks results in profound and sustained HBV DNA suppression in untreated subjects with chronic HBV infection
Saved in:
Published in | Journal of hepatology Vol. 82; pp. S836 - S837 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
01.05.2025
|
Online Access | Get full text |
ISSN | 0168-8278 |
DOI | 10.1016/S0168-8278(25)02146-4 |
Cover
ISSN: | 0168-8278 |
---|---|
DOI: | 10.1016/S0168-8278(25)02146-4 |